Jonathan D Casey Selected Research

Isotonic Solutions

1/2021	Effect of balanced crystalloids versus saline on urinary biomarkers of acute kidney injury in critically ill adults.
1/2021	Time to First Culture Positivity for Gram-Negative Rods Resistant to Ceftriaxone in Critically Ill Adults.
1/2021	Effect of Early Balanced Crystalloids Before ICU Admission on Sepsis Outcomes.
12/2019	Balanced Crystalloids versus Saline in Sepsis. A Secondary Analysis of the SMART Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonathan D Casey Research Topics

Disease

29	COVID-19 11/2022 - 01/2020
12	Critical Illness (Critically Ill) 01/2022 - 01/2018
5	Infections 05/2022 - 11/2020
4	Hypoxia (Hypoxemia) 07/2022 - 11/2018
4	Respiratory Insufficiency (Respiratory Failure) 03/2022 - 01/2020
4	Sepsis (Septicemia) 01/2021 - 11/2017
2	Disease Progression 10/2022 - 11/2021
2	Human Influenza (Influenza) 10/2021 - 01/2021
2	Shock 12/2020 - 12/2018
1	Heart Arrest (Cardiac Arrest) 01/2022
1	Hypercapnia 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 12/2020
1	Reinfection 11/2020
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 11/2020
1	Acidosis 11/2020
1	Thromboembolism 11/2020
1	Hemorrhage 11/2020
1	Wounds and Injuries (Trauma) 11/2020
1	Dyspnea (Shortness of Breath) 01/2020
1	Dysphonia (Spastic Dysphonia) 01/2020
1	Pulmonary Edema 01/2019
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2019
1	Hypovolemia 12/2018
1	Neoplasms (Cancer) 11/2009
1	Glioma (Gliomas) 11/2009
1	Breast Neoplasms (Breast Cancer) 11/2009

Drug/Important Bio-Agent (IBA)

16	VaccinesIBA 10/2022 - 01/2021
12	mRNA VaccinesIBA 10/2022 - 07/2021
6	COVID-19 VaccinesIBA 10/2022 - 05/2021
5	Crystalloid SolutionsIBA 01/2021 - 12/2019
4	Oxygen (Dioxygen)IBA 07/2022 - 11/2018
4	Isotonic SolutionsIBA 01/2021 - 12/2019
3	AntibodiesIBA 11/2022 - 09/2020
3	BNT162 VaccineIBA 03/2022 - 11/2021
3	Messenger RNA (mRNA)IBA 02/2022 - 11/2021
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022 - 01/2020
2	2019-nCoV Vaccine mRNA-1273IBA 03/2022 - 01/2022
2	Dihydrotachysterol (AT 10)IBA 10/2021 - 01/2021
2	Saline SolutionIBA 01/2021 - 11/2020
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2009
1	Ad26COVS1IBA 10/2022
1	Influenza Vaccines (Influenza Vaccine)FDA Link 10/2021
1	cyclo(Arg-Pro) (CI 4)IBA 10/2021
1	Immunoglobulin G (IgG)IBA 09/2021
1	ChloridesIBA 01/2021
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2021
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	AngiotensinsIBA 01/2021
1	Angiotensin-Converting Enzyme 2IBA 01/2021
1	Plasmalyte AIBA 01/2021
1	Ringer's LactateIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Lipocalin-2IBA 01/2021
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 12/2020
1	Sodium Chloride FDA LinkGeneric 11/2020
1	Coffee FDA Link 09/2020
1	DiureticsIBA 01/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2017
1	Dendrimers (Dendrons)IBA 11/2009
1	GABA-A Receptors (GABA(A) Receptor)IBA 11/2009
1	LigandsIBA 11/2009

Therapy/Procedure

7	Artificial Respiration (Mechanical Ventilation) 10/2022 - 01/2020
4	Extracorporeal Membrane Oxygenation 05/2022 - 11/2020
4	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2022 - 01/2019
3	Cannula 07/2022 - 11/2020
3	Resuscitation 01/2021 - 12/2018
2	Noninvasive Ventilation 01/2021 - 01/2020
2	Therapeutics 01/2021 - 12/2019
1	Anesthesia 01/2022
1	Long-Term Care 01/2021
1	Length of Stay 11/2020
1	Personal Protective Equipment 09/2020
1	Intravenous Infusions 12/2019
1	Airway Management 11/2018
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2018